Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Playground Global
BioCentury | Sep 4, 2024
Management Tracks
Evers leaving Evotec as CBO
Plus: C-suite changes at Dyne, and updates from Novocure, Amphista, reMYND, Belite Bio, Forward and more
BioCentury | Aug 1, 2024
Finance
Venture Report: venBio closes new $528M fifth fund
Plus: Airna, ReviR, LTZ and Synthetica draw Series A cash, while Outpace, Confo and Healx refill their coffers
BioCentury | Feb 29, 2024
Management Tracks
Umoja names Russell CFO
Plus: a Playground promotion and updates from CHO Plus and Rapport
BioCentury | Feb 22, 2024
Finance
Venture report: Frontier enters clinic with $80M round; ORI’s new $260M fund
Plus: Launches for Sofinnova-backed AI company Bioptimus, peptide start-up Insamo
BioCentury | Dec 15, 2023
Finance
Dec. 14 Quick Takes: Playground Global raises $410M third fund
Plus: ATP launches small molecule discovery company Deep Apple and more from Apellis, Moderna, Merck, Amgen and Huilly
BioCentury | Oct 17, 2023
Finance
Playground Global’s on-ramp for first-time founders
Via early-stage biotech financing, the firm focuses on data-generating platforms and best-in-class lead assets
BioCentury | Aug 9, 2023
Management Tracks
AI Proteins names Noah Beerman as CEO, Alles chair
Plus: Emergent cuts include COO, and updates from Playground, Viracta, Dunad
BioCentury | Aug 3, 2023
Finance
Aug. 3 Quick Takes: Kyverna extends B round to $145M
Plus: Aravive low on cash after ovarian cancer miss, Agios to develop Alnylam program, and updates from Seagen and Amber
BioCentury | Jan 26, 2023
Finance
Jan. 25 Finance Quick Takes: Pliant leads follow-on pack
Plus: Dimension launches with $350M fund for start-ups, and updates from Atomic AI
BioCentury | Dec 6, 2022
Data Byte
Pulmocide joins trio of start-ups with venture raises
Entact Bio, Vega mark debuts alongside $52M series C extension for U.K.’s Pulmocide
Items per page:
1 - 10 of 20